DIONNA MCFERRIN: Open Payments
NPI 1841746443 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 19 payments from 8 companies in 2025. Trend: 2023 $329 · 2024 $305 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $149 |
| ABBVIE INC. | 5 | $93 |
| Alkermes, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: Auvelity, VRAYLAR, ARISTADA, INGREZZA, COBENFY, FANAPT, CAPLYTA, AUSTEDO XR.
Industry payments across WI — which companies pay providers there.
